Domov › Rakovina pankreasu › Texas › Dallas
Klinické štúdie Rakovina pankreasu v meste Dallas, TX
22 štúdií pre Rakovina pankreasu hľadá účastníkov v zariadeniach v meste Dallas a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial
Prebieha náborFáza 3
- University of Texas Southwestern Medical Center, Dallas
DESTINY-PANTUMOUR04
Prebieha náborObservačná štúdia
- Research Site, Dallas
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Prebieha náborFáza 2/3
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- University of Texas Southwestern Medical Center-Zale Lipshy University Hospital, Dallas
- a 1 ďalších
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Prebieha náborFáza 3
- Texas Oncology - DFW, Dallas
- University of Texas, Southwestern Medical Center, Dallas
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Prebieha náborFáza 3
- Investigative Site US067, Dallas
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Prebieha náborFáza 3
- UT Southwestern Medical Center at Dallas, Dallas
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Prebieha náborFáza 1
- NEXT - Dallas, Dallas
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
Prebieha náborObservačná štúdia
- University of Texas Southwestern/Children's Medical Center, Dallas
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Prebieha náborObservačná štúdia
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Prebieha náborFáza 1
- Ut Southwestern, Dallas
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
Prebieha náborFáza 1
- University of Texas Southwestern Medical Center, Dallas
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Prebieha náborFáza 3
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Prebieha náborFáza 2
- Texas Oncology - DFW, Dallas
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Prebieha náborFáza 1
- Sarah Cannon Research Institute at Mary Crowley, Dallas
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Prebieha náborFáza 1/2
- Mary Crowley Cancer Research, Dallas
Evaluation of Resection Techniques for Pancreatic Tumors
Prebieha náborObservačná štúdia
- Methodist Dallas Medical Center, Dallas
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- NEXT Oncology - Dallas, Dallas
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Prebieha náborFáza 2
- Ohio State University-Telemedicine, Dallas
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
Prebieha náborFáza 1/2
- NEXT Oncology Dallas, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Dallas
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Prebieha náborFáza 1/2
- Mary Crowley Cancer Research, Dallas
- University of Texas Southwestern Medical Center, Dallas
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
Prebieha náborObservačná štúdia
- Methodist Digestive Institute, Dallas
Štúdie Rakovina pankreasu v iných mestách
- Houston, TX61 štúdií
- New York City, NY60 štúdií
- Boston, MA43 štúdií
- Nashville, TN39 štúdií
- Los Angeles, CA35 štúdií
- St. Louis, MO33 štúdií
- Arlington, VA33 štúdií
- San Antonio, TX31 štúdií
- Baltimore, MD30 štúdií
- Philadelphia, PA26 štúdií
- Tampa, FL26 štúdií
- Durham, NC24 štúdií
Iné štúdie v Dallas
- Rakovina prsníka56 štúdií
- Nemalobunkový karcinóm pľúc52 štúdií
- Metastatická rakovina42 štúdií
- Srdcové zlyhanie42 štúdií
- Rakovina (všetky typy)37 štúdií
- Rakovina prostaty36 štúdií
- Kolorektálny karcinóm33 štúdií
- Obézita30 štúdií
- Rakovina vaječníkov29 štúdií
- Rakovina močového mechúra27 štúdií
- Rakovina pľúc27 štúdií
- Rakovina endometria24 štúdií
Z ClinicalTrials.gov, dáta načítané 7. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.